Media headlines about PetMed Express (NASDAQ:PETS) have been trending somewhat positive on Sunday, Accern Sentiment reports. Accern scores the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. PetMed Express earned a news sentiment score of 0.20 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.6761971771297 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Here are some of the news headlines that may have effected Accern Sentiment Analysis’s analysis:

Shares of PetMed Express (PETS) opened at 47.76 on Friday. The firm’s 50 day moving average is $43.59 and its 200 day moving average is $30.19. PetMed Express has a 52-week low of $18.90 and a 52-week high of $50.90. The stock has a market capitalization of $969.15 million, a price-to-earnings ratio of 36.74 and a beta of 0.99.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Monday, July 24th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07. The firm had revenue of $79.66 million during the quarter, compared to analysts’ expectations of $77.32 million. PetMed Express had a return on equity of 28.67% and a net margin of 10.34%. The firm’s revenue was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 earnings per share. Equities analysts expect that PetMed Express will post $1.44 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, August 18th. Shareholders of record on Monday, August 7th will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 1.68%. The ex-dividend date is Thursday, August 3rd. PetMed Express’s dividend payout ratio (DPR) is 61.54%.

A number of research firms recently weighed in on PETS. Noble Financial reaffirmed a “hold” rating on shares of PetMed Express in a research note on Wednesday, July 26th. Northcoast Research raised shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price objective for the company in a research note on Monday, July 24th. Craig Hallum lowered shares of PetMed Express from a “buy” rating to a “hold” rating in a research note on Tuesday, July 11th. Finally, Zacks Investment Research raised shares of PetMed Express from a “hold” rating to a “strong-buy” rating and set a $38.00 price objective for the company in a research note on Wednesday, May 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, one has given a buy rating and one has given a strong buy rating to the company’s stock. PetMed Express currently has a consensus rating of “Hold” and a consensus price target of $35.00.

ILLEGAL ACTIVITY WARNING: “PetMed Express (PETS) Earns Coverage Optimism Score of 0.20” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/08/13/petmed-express-pets-earns-coverage-optimism-score-of-0-20.html.

In other PetMed Express news, Director Robert C. Schweitzer sold 2,500 shares of PetMed Express stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $49.18, for a total transaction of $122,950.00. Following the transaction, the director now owns 88,834 shares of the company’s stock, valued at $4,368,856.12. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Frank J. Formica sold 5,000 shares of PetMed Express stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $35.32, for a total value of $176,600.00. Following the transaction, the director now directly owns 46,000 shares in the company, valued at approximately $1,624,720. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 24,333 shares of company stock worth $1,126,330. 4.00% of the stock is currently owned by corporate insiders.

PetMed Express Company Profile

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Insider Buying and Selling by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.